Publications by authors named "Patrick Hayden"

Claim this Profile
O
Outcomes following different upfront stem cell transplantation strategies for multiple myeloma: a statistical perspective on behalf of the Chronic Malignancies Working Party of the EBMT.
Simona Iacobelli, Stefan Schönland, Linda Koster, Didier Blaise, Emma Nicholson, Patrick J Hayden

Bone Marrow Transplant· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Entanglement Cost for Infinite-Dimensional Physical Systems.
Hayata Yamasaki, Kohdai Kuroiwa, Patrick Hayden, Ludovico Lami

Commun Math Phys· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of age on survival and excess mortality after autologous hematopoietic cell transplantation in newly diagnosed multiple myeloma patients.
Shohei Mizuno, Luuk Gras, Laurien G A Baaij, Linda Koster, Anita D'Souza, Patrick J Hayden

Haematologica· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of cryopreserved and noncryopreserved peripheral blood hematopoietic stem cells for autologous transplantation in multiple myeloma: a study from the chronic malignancies working party of the EBMT.
Mohammed Amine Bekadja, Luuk Gras, Laurien Baaij, Linda Koster, Nada Hamad, Patrick J Hayden

Cytotherapy· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic hematopoietic cell transplantation for therapy-related myeloid neoplasms arising following treatment for multiple myeloma: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT.
Kavita Raj, Diderik-Jan Eikema, Sarah Lawless, Linda Koster, Desiree Kunadt, Patrick Hayden

Bone Marrow Transplant· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Satisfactory outcomes following a second autologous hematopoietic cell transplantation for multiple myeloma in poor stem cell mobilizers: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT.
Matjaz Sever, Joanna Drozd-Sokolowska, Luuk Gras, Linda Koster, Frantisek Folber, Patrick J Hayden

Bone Marrow Transplant· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global characteristics and outcomes of autologous hematopoietic stem cell transplantation for newly diagnosed multiple myeloma: A study of the worldwide network for blood and marrow transplantation (WBMT).
Laurent Garderet, Luuk Gras, Linda Koster, Laurien Baaij, Nada Hamad, Patrick John Hayden

Am J Hematol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcomes and renal responses following autologous hematopoietic stem cell transplantation for light chain deposition disease: a retrospective study on behalf of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.
Laurent Garderet, Luuk Gras, Linda Koster, Liesbeth De Wreede, Rovira Montserrat, Patrick Hayden

Haematologica· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does IPSS-R downstaging before transplantation improve the prognosis of patients with myelodysplastic neoplasms?
Christof Scheid, Diderik-Jan Eikema, Michel van Gelder, Urpu Salmenniemi, Johan Maertens, Patrick Hayden

Blood· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stem Cell Mobilization Performed with Different Doses of Cytarabine in Plasma Cell Myeloma Patients Relapsing after Previous Autologous Hematopoietic Cell Transplantation-A Multicenter Report by the Polish Myeloma Study Group.
Joanna Drozd-Sokołowska, Anna Waszczuk-Gajda, Magdalena Topczewska, Martyna Maciejewska, Magdalena Dutka, Patrick J Hayden

Cancers (Basel)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mismatched related donor allogeneic haematopoietic cell transplantation compared to other donor types for Ph+ chronic myeloid leukaemia: A retrospective analysis from the Chronic Malignancies Working Party of the EBMT.
Francesco Onida, Luuk Gras, Junran Ge, Linda Koster, Rose-Marie Hamladji, Patrick J Hayden

Br J Haematol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequence not salvage.
Douglas W Sborov, Gliceida Galarza Fortuna, Patrick J Hayden

Br J Haematol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In the era of Bortezomib-based Induction, intensification of Melphalan-based conditioning with Bortezomib does not improve Survival Outcomes in newly diagnosed Multiple Myeloma: a study from the Chronic Malignancies Working Party of the EBMT.
Meral Beksac, Diderik-Jan Eikema, Linda Koster, Cyrille Hulin, Xavier Poiré, Patrick J Hayden

Bone Marrow Transplant· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of maintenance therapy following autologous stem cell transplantation in newly diagnosed multiple myeloma: Considerations on behalf of the Chronic Malignancies Working Party of the EBMT.
Angela Hwang, Patrick Hayden, Charlotte Pawlyn, Donal McLornan, Laurent Garderet

Br J Haematol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic hematopoietic cell transplantation for VEXAS syndrome: results of a multicenter study of the EBMT.
Carmelo Gurnari, Linda Koster, Laurien Baaij, Mael Heiblig, Ibrahim Yakoub-Agha, Patrick J Hayden

Blood Adv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of CMML patients undergoing allo-HCT are significantly worse compared to MDS-a study of the CMWP of the EBMT.
Alicia Rovó, Luuk Gras, Brian Piepenbroek, Nicolaus Kröger, H Christian Reinhardt, Patrick Hayden

Am J Hematol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early liver complications after allogeneic haematopoietic stem cell transplantation in patients with myelofibrosis: A study on behalf of the Chronic Malignancies Working Party of the EBMT.
Marie Robin, Luuk Gras, Linda Koster, Nico Gagelmann, Gwendolyn van Gorkom, Patrick J Hayden

Br J Haematol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Graft-versus-Host Disease Prophylaxis with Post- Transplantation Cyclophosphamide in Chronic Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation from an Unrelated or Mismatched Related Donor: A Comparative Study from the Chronic Malignancies Working Party of the EBMT (CMWP-EBMT).
Guillermo Ortí, Luuk Gras, Linda Koster, Aleksander Kulagin, Jenny Byrne, Patrick J Hayden

Transplant Cell Ther· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma Treated with Radiation Therapy: A Case Report and Review of the Literature.
Paul Armstrong, Patrick Hayden, Michael Jeffers, Lisa Fitzpatrick, Aoife Mcknight

Case Rep Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carfilzomib, lenalidomide and dexamethasone followed by a second ASCT is an effective strategy in first relapse multiple myeloma: a study on behalf of the Chronic malignancies working party of the EBMT.
Rémi Tilmont, Ibrahim Yakoub-Agha, Diderik-Jan Eikema, Nienke Zinger, Mathias Haenel, Patrick J Hayden

Bone Marrow Transplant· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: An early post-transplant relapse prediction score in multiple myeloma: a large cohort study from the chronic malignancies working party of EBMT.
Meral Beksac, Simona Iacobelli, Linda Koster, Jan Cornelissen, Laimonas Griskevicius, Patrick J Hayden

Bone Marrow Transplant· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of newly diagnosed extramedullary myeloma on outcome after first autograft followed by maintenance: A CMWP-EBMT study.
Nico Gagelmann, Dirk-Jan Eikema, Linda Koster, Tanja Netelenbos, Andrew McDonald, Patrick J Hayden

Eur J Haematol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An early post-transplant relapse prediction score in multiple myeloma: a large cohort study from the chronic malignancies working party of EBMT.
Meral Beksac, Simona Iacobelli, Linda Koster, Jan Cornelissen, Laimonas Griskevicius, Patrick J Hayden

Bone Marrow Transplant· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of in vitro rat and human airway epithelial models for acute inhalation toxicity testing.
Joanne Wallace, George R Jackson, Yulia Kaluzhny, Seyoum Ayehunie, Alison B Lansley, Patrick J Hayden

Toxicol Sci· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The European landscape on allogeneic haematopoeietic cell transplantation in Chronic Lymphocytic Leukaemia between 2009 and 2019: a perspective from the Chronic Malignancies Working Party of the EBMT.
Olivier Tournilhac, Michel van Gelder, Dirk-Jan Eikema, Nienke Zinger, Peter Dreger, Patrick J Hayden

Bone Marrow Transplant· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis